“These Hepatitis C drugs should be looked at” says MSF Access to Medicines Campaign

On February 7th, Rosa and Benjamin had a meeting with Judit Rius and Rohit Malpani from MSF Access to medicines campaign. Attending was also Rachel Kiddel-Monroe and Bryan Collinsworth.

Drug bios was enthusiastically discussed and MSF gave us a list of potential drugs to look into. This list includes drugs for HIV, TB resistance, HPV and HCV.

We have decided that the Drug Bios project as a pilot project will proceed with the drugs concerning Hepatitis C. This is a great starting point as Hepatitis C currently affect more that hundreds of millions around the world. Hepatitis C will possibly not only be a LDC and MDC problem, but also a problem for the developed countries. Reason for this, being that the prices for these future vaccine, are predicted to be vastly overpriced!!!

LIST:

Sofosbuvir
Daclatasvir
Simeprevir
Ledipasvir
Asunapravir

NOW! LETS GET GOING! WE NEED TO FIND SOME PUBLIC RESEARCH ON THESE!

Let the revolution begin! GO UEAM!

– Benjamin

Advertisements